GlassScriptPhysician profile
Jessica Rapp
NPI 1306164637
$718.30
in general payments reported to CMS, 2019-2025
23 companies · $93.37 in 2025
The $93.37 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $33.84 · 2021: $250 · 2022: $199 · 2025: $93.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $90.68 | 2019-2022 | |
| Pfizer INC. | $80.30 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $72.31 | 2022 | |
| Abbvie INC. | $71.60 | 2021-2025 | |
| Daiichi Sankyo INC. | $38.85 | 2021 | |
| Glaxosmithkline, LLC. | $37.72 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.59 | 2022 | |
| Xeris Pharmaceuticals, INC. | $30.06 | 2021 | |
| Astellas Pharma US INC | $26.94 | 2021 | |
| Dexcom, INC. | $25.67 | 2021 | |
| Axsome Therapeutics, INC. | $21.43 | 2025 | Auvelity |
| Abbott Laboratories | $20.42 | 2025 | Freestyle Libre 3 |
| Nestle Healthcare Nutrition INC. | $20.30 | 2022 | |
| Terumo Medical Corporation | $19.09 | 2020 | |
| Esperion Therapeutics, INC. | $18.73 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.90 | 2025 | Farxiga |
| Valeritas, INC. | $17.31 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $15.59 | 2021 | |
| Jazz Pharmaceuticals INC. | $15.11 | 2022 | |
| Novartis Pharmaceuticals Corporation | $12.64 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.31 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $11.41 | 2019 | |
| Lilly USA, LLC | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Rapp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.